Date Title Description PDF
22 Jun 2021 On significant placements in financial instruments Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. Download
22 Jun 2021 On significant placements in financial instruments Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. Download
29 Apr 2021 On business and financial situation The Company informs about the increase of its fill-finish capacity for the manufacture of Moderna’s COVID-19 vaccine outside the United States.     Download
12 Apr 2021 On business and financial situation The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine. Download
02 Mar 2021 On business and financial situation The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download

Pages

Date Title Description PDF
26 Feb 2020 Information on P&L ROVI releases the press release related to the full year 2019 financial results Download
26 Feb 2020 Information on P&L ROVI releases the full year 2019 results presentation Download

Pages

Date Title Description PDF
21 Feb 2012 Información sobre resultados (2) Download
21 Feb 2012 Información sobre resultados Download
21 Feb 2012 Informe Anual de Gobierno Corporativo Download
15 Feb 2012 Cambios en política de inversión, áreas de negocio y líneas de productos Download
22 Dec 2011 Composición del Consejo de Administración Download

Pages